@article{TAU24753,
author = {Randall J. Brenneman and Edward Soffen and Hiram A. Gay and Peter F. Orio III and John P. Christodouleas and John C. Baumann and Brian C. Baumann},
title = {Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/RTOG 0526)},
journal = {Translational Andrology and Urology},
volume = {8},
number = {Suppl 3},
year = {2019},
keywords = {},
abstract = {External beam radiotherapy (EBRT) is the most commonly employed non-surgical treatment for prostate cancer in the modern era (1). Local recurrence of prostate cancer after EBRT occurs in up to 15% of patients (2-4). Local recurrence is not only common and often symptomatic, but is also a risk factor for developing distant disease. Dose-escalated EBRT reduced local recurrence risk and need for salvage local therapy in a large Phase III trial (5); however, local recurrence after EBRT remains an important problem. The morbidity and mortality associated with local failure suggests a possible role for local salvage therapies for appropriately selected patients (6,7).},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/24753}
}